Jing Li

5PUBLICATIONS
16CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2024
Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling.

Zhijun Geng, Lugen Zuo, Jing Li

|May 14, 2024
Complanatuside A ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by regulating the Th17/Treg balance via the JAK2/STAT3 signaling pathway.

Yueyue Wang, Xue Song, Yongsheng Xia

|Dec 04, 2021
Epac-2 ameliorates spontaneous colitis in Il-10-/- mice by protecting the intestinal barrier and suppressing NF-κB/MAPK signalling.

Xue Song, Hexin Wen, Lugen Zuo

|Jun 29, 2019
Bryostatin-1 ameliorated experimental colitis in Il-10-/- Mice by protecting the intestinal barrier and limiting immune dysfunction.

Lugen Zuo, Jing Li, Sitang Ge

|Jun 19, 2019
Spontaneous colitis in IL-10-deficient mice was ameliorated via inhibiting glutaminase1.

Jing Li, Lugen Zuo, Yun Tian

Pageof 1

Frequent Collaborators

3 joint publications

Lugen Zuo

2 joint publications

Yueyue Wang

2 joint publications

Xue Song

2 joint publications

Jianguo Hu